GO:0052873 FMN reductase (NADPH) activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0052873 defines FMN reductase (NADPH) activity, the catalysis of FMNH2 + NADP+ = FMN + NADPH + 2 H+.
• The reaction is a hydride-transfer step that recycles the flavin cofactor FMN using NADPH as the electron donor.
• Enzymes with this activity are found in bacteria, yeast, and as domains of larger eukaryotic redox proteins such as cytochrome P450 reductase [2,3,7].
• The FMN-containing domain of cytochrome P450 reductase is a paradigm for how this activity is allosterically regulated within a multidomain enzyme.
• Structural studies of ArsH and FMN-dependent NADPH-indigo reductase homologs reveal the molecular basis of NADPH-dependent FMN reduction [4,8].
• Loss or gain of FMN reductase (NADPH) activity can alter redox homeostasis, drug metabolism, and iron acquisition in pathogens [2,6].
Description
FMN reductase (NADPH) activity, encoded by the Gene Ontology term GO:0052873, is a molecular function that catalyzes the reduction of flavin mononucleotide (FMN) to its reduced form FMNH2 using NADPH as the electron donor. The formal reaction is FMNH2 + NADP+ = FMN + NADPH + 2 H+, and the activity is also known as NADPH dehydrogenase (FMN) activity. This reaction is central to flavin homeostasis and to the function of flavoenzymes that require reduced FMN for catalysis. Researchers study GO:0052873 because it underpins redox reactions in primary metabolism, xenobiotic detoxification, and host-pathogen interactions [2,6]. In eukaryotes, the best-characterized example is the FMN-containing domain of NADPH-cytochrome P450 reductase, which transfers electrons from NADPH to cytochrome P450 enzymes [2,3]. In bacteria and yeast, standalone FMN reductases with this activity have been isolated and structurally characterized, providing insight into flavin-based redox chemistry [4,7,8]. The term is therefore a key node linking flavin cofactor biology to cellular redox networks and drug metabolism [2,8].
FMN reductase (NADPH) activity At A Glance
| GO ID | GO:0052873 |
|---|---|
| GO term | FMN reductase (NADPH) activity |
| Ontology | molecular_function |
| Synonym | NADPH dehydrogenase (FMN) activity |
| Definition | Catalysis of the reaction: FMNH2 + NADP+ = FMN + NADPH + 2 H+ |
| Major function | Reduction of FMN to FMNH2 using NADPH as electron donor |
| Cofactor | Flavin mononucleotide (FMN) |
| Electron donor | NADPH |
| Representative enzymes | FMN-containing domain of cytochrome P450 reductase, ArsH, FMN-dependent NADPH-indigo reductase homologs |
What Is GO:0052873?
GO:0052873 describes the catalytic activity of an enzyme that converts oxidized FMN to reduced FMNH2 while oxidizing NADPH to NADP+. In the reverse direction, the same activity can use FMNH2 to reduce NADP+ to NADPH. The term is defined by the chemical equation FMNH2 + NADP+ = FMN + NADPH + 2 H+, and it is classified as a molecular function in the Gene Ontology. The synonym NADPH dehydrogenase (FMN) activity reflects the ability of these enzymes to act as dehydrogenases that use FMN as a cofactor. This activity is distinct from FMN reductases that use NADH instead of NADPH, and it is often found in multidomain redox proteins where the FMN-binding domain shuttles electrons between NADPH and a terminal acceptor [2,8].
Why Is FMN reductase (NADPH) activity Important in Cell Biology?
FMN reductase (NADPH) activity is important because it controls the redox state of the FMN cofactor, which in turn regulates the activity of diverse flavoenzymes involved in metabolism, detoxification, and oxidative stress responses [2,8]. In eukaryotic cytochrome P450 systems, this activity is embedded in NADPH-cytochrome P450 reductase and is essential for electron transfer to P450 enzymes that metabolize drugs and endogenous compounds [2,3]. In pathogens such as Leishmania and Shigella, FMN reductase (NADPH) activity contributes to iron acquisition and redox defense, making it a potential drug target [6,8]. The activity also influences lipid peroxidation and cellular oxidative damage, as shown in early studies of NADPH-cytochrome c reductase. Because the reaction is reversible and depends on NADPH availability, it integrates flavin metabolism with the cellular redox pool.
• Provides reduced FMN for flavoenzymes involved in drug metabolism and xenobiotic detoxification.
• Supports electron transfer from NADPH to cytochrome P450 enzymes in eukaryotes [2,3].
• Contributes to iron acquisition and redox homeostasis in pathogenic protozoa.
• Plays a role in oxidative stress responses and lipid peroxidation.
• Is a target for understanding flavin-based redox chemistry in bacteria and yeast [4,7,8].
• Links NADPH supply to flavin cofactor recycling in primary metabolism.
• Can influence the activity of indigo-reducing enzymes used in biotechnology.
• Serves as a model for allosteric regulation in multidomain redox proteins.
• May affect the efficacy of drugs that require P450-mediated activation.
• Provides a mechanistic basis for designing inhibitors against microbial FMN reductases.
Molecular Mechanism of FMN reductase (NADPH) activity
Substrate Binding and Hydride Transfer
In simple terms: The enzyme grabs FMN and NADPH, then moves a hydride from NADPH to FMN.
The catalytic cycle begins with binding of oxidized FMN and NADPH in the active site. Structural studies of the Shigella flexneri ArsH protein, which has NADPH-dependent FMN reductase activity, reveal a fold that positions the flavin isoalloxazine ring near the nicotinamide ring of NADPH. This arrangement allows a hydride ion to be transferred from the C4 position of the nicotinamide to the N5 position of the flavin, reducing FMN to FMNH2. The reaction is reversible, and the equilibrium can favor either direction depending on the redox state of the cell.
Flavin Cofactor Chemistry
In simple terms: FMN is the molecule that actually accepts and donates electrons during the reaction.
FMN is a tightly bound cofactor in enzymes with GO:0052873 activity. Its isoalloxazine ring can exist in oxidized, semiquinone, and fully reduced forms, allowing it to participate in one- and two-electron transfer reactions. The NADPH-dependent reduction of FMN to FMNH2 is a two-electron process, but the flavin can also engage in one-electron chemistry when interacting with other redox partners. The redox potential of the bound FMN is tuned by the protein environment, which influences the direction and efficiency of electron transfer.
Electron Transfer to Terminal Acceptors
In simple terms: After FMN is reduced, the electrons can be passed to other proteins or molecules.
In multidomain enzymes such as NADPH-cytochrome P450 reductase, the FMN-containing domain receives electrons from NADPH via FAD and then transfers them to cytochrome P450 enzymes [2,3]. The FMN domain must physically interact with the P450 heme domain, and this interaction is regulated by the linker region between the membrane-binding segment and the FMN domain. Allosteric modulation of the FMN-containing domain by NADPH and other ligands can influence the rate of electron transfer to the terminal acceptor. In standalone FMN reductases, the reduced FMNH2 can directly reduce substrates such as indigo or ferric iron complexes [4,6].
Regulation by Protein-Protein Interactions and Linkers
In simple terms: The enzyme's activity can be turned up or down by how its parts move and interact.
The activity of FMN reductase (NADPH) domains is not constitutive; it is regulated by conformational changes and protein-protein interactions. In cytochrome P450 reductase, a flexible linker of eight amino acids between the membrane-binding segment and the FMN domain is necessary for optimal activity, suggesting that domain motion controls electron transfer. Allosteric modulation of the FMN-containing domain by NADPH or other effectors can alter the redox potential of the flavin and the rate of hydride transfer. These regulatory mechanisms ensure that electron transfer is coupled to the availability of NADPH and the presence of a suitable terminal acceptor [2,3].
Key Genes Involved in GO:0052873 FMN reductase (NADPH) activity
The following genes and proteins are experimentally linked to FMN reductase (NADPH) activity or its regulation, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CYP176A1 | Cytochrome P450 enzyme that receives electrons from FMN-containing reductases | Model for studying electron transfer from FMN reductase domains |
| POR (cytochrome P450 reductase) | Contains an FMN domain with NADPH-dependent FMN reductase activity | Paradigm for allosteric regulation and linker function [2,3] |
| ArsH (Shigella flexneri) | Standalone NADPH-dependent FMN reductase | Structural model for FMN binding and catalysis |
| FMN-dependent NADPH-indigo reductase homolog (Bacillus cohnii) | Reduces indigo using NADPH and FMN | Biotechnological and structural studies |
| LFR1 (Leishmania amazonensis) | Bifunctional ferric iron reductase with NADPH oxidase activity | Links FMN reductase activity to iron acquisition |
| NADH (NADPH)-cytochrome c reductase (yeast) | FMN-containing reductase from top-fermenting ale yeast | Physicochemical characterization of the enzyme |
| NADPH-cytochrome c reductase (rabbit liver) | Microsomal reductase involved in lipid peroxidation | Early evidence for redox roles |
| FAD-containing domain of POR | Accepts electrons from NADPH and passes them to FMN domain | Electron transfer chain in P450 systems |
| FMN domain of POR | Reduces FMN using NADPH | Core catalytic unit for GO:0052873 [2,3] |
| Cytochrome P450cin (CYP176A1) | Bacterial P450 that interacts with FMN reductases | Model for P450-reductase coupling |
| ArsH homologs | Putative FMN reductases in bacteria | Comparative structural studies |
| Indigo reductase homologs | FMN-dependent NADPH oxidoreductases | Enzyme engineering and biocatalysis |
| Ferric iron reductase (LFR1) | Reduces iron using NADPH and FMN | Pathogen survival and virulence |
| NADPH dehydrogenase (FMN) | Synonym for the activity | Functional annotation in databases |
| Cytochrome c reductase (FMN-containing) | Yeast enzyme with NADPH-dependent activity | Biochemical model for flavin chemistry |
| Microsomal NADPH-cytochrome c reductase | Rabbit liver enzyme with lipid peroxidation activity | Oxidative stress studies |
How Is FMN reductase (NADPH) activity Regulated?
FMN reductase (NADPH) activity is regulated at multiple levels. In cytochrome P450 reductase, allosteric modulation by NADPH and the conformational state of the FMN-containing domain control the rate of electron transfer to P450 enzymes. The flexible linker between the membrane-binding segment and the FMN domain is required for optimal activity, indicating that domain motion is a regulatory feature. In pathogens, the activity can be influenced by iron availability and oxidative stress, as seen for Leishmania ferric iron reductase. Additionally, the redox state of the NADPH/NADP+ pool directly affects the direction and rate of the reaction.
FMN reductase (NADPH) activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| POR | Drug metabolism disorders, oxidative stress | Knockout or point-mutation cell lines [2,3] |
| LFR1 | Leishmaniasis, iron acquisition | Leishmania knockout or overexpression |
| ArsH | Bacterial infection, redox defense | Shigella knockout or complementation |
| FMN-dependent indigo reductase | Biotechnology, enzyme engineering | Recombinant overexpression in E. coli |
| Cytochrome c reductase | Lipid peroxidation, oxidative damage | Microsomal assays with inhibitors |
Drug Metabolism and Cytochrome P450 Dysfunction
FMN reductase (NADPH) activity is essential for electron transfer to cytochrome P450 enzymes, which metabolize drugs and endogenous compounds [2,3]. Allosteric modulation of the FMN-containing domain of cytochrome P450 reductase can alter P450 activity, potentially affecting drug efficacy and toxicity. Defects in this electron transfer chain have been linked to impaired drug metabolism and oxidative stress [2,3].
Pathogen Survival and Virulence
In Leishmania amazonensis, the bifunctional ferric iron reductase LFR1 uses NADPH-dependent FMN reductase activity to reduce iron, which is critical for parasite survival and virulence. Similarly, Shigella flexneri ArsH has NADPH-dependent FMN reductase activity that may contribute to redox defense during infection. These enzymes are potential targets for antimicrobial drug development [6,8].
Oxidative Stress and Lipid Peroxidation
Early studies showed that NADPH-cytochrome c reductase from rabbit liver microsomes mediates lipid peroxidation, linking FMN reductase (NADPH) activity to oxidative damage. This activity can contribute to cellular oxidative stress when electron transfer is uncoupled from terminal acceptors. Understanding this process is relevant to diseases involving oxidative stress, such as neurodegeneration and inflammation.
From FMN reductase (NADPH) activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of FMN reductase (NADPH) activity impair P450-mediated drug metabolism? | POR knockout cell line [2,3] |
| How does a point mutation in the FMN domain affect electron transfer? | Point-mutation knock-in of POR |
| Can a tagged FMN reductase be used to track localization? | Knock-in of GFP or FLAG tag |
| Does overexpression of LFR1 increase iron uptake? | Leishmania overexpression model |
| Is ArsH required for Shigella survival under oxidative stress? | Shigella knockout and oxidative stress assays |
| Can indigo reductase activity be enhanced by directed evolution? | Overexpression and screening in E. coli |
How to Study the FMN reductase (NADPH) activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NADPH oxidation assay | Consumption of NADPH at 340 nm | Enzymatic activity of purified FMN reductases |
| FMN reduction assay | Formation of FMNH2 | Cofactor reduction kinetics |
| Cytochrome c reduction assay | Electron transfer to cytochrome c | P450 reductase activity [2,3] |
| X-ray crystallography | Three-dimensional structure of enzyme-cofactor complex | Active site and allosteric mechanism [4,8] |
| Site-directed mutagenesis | Effect of specific amino acid changes on activity | Linker and domain function |
| Knockout cell lines | Loss of function phenotype | Drug metabolism and oxidative stress [2,6] |
| Iron uptake assay | Intracellular iron levels | Pathogen virulence |
| Lipid peroxidation assay | Malondialdehyde or related products | Oxidative damage |
Enzymatic Assays for FMN Reductase Activity
Direct measurement of GO:0052873 activity uses NADPH oxidation monitored at 340 nm or FMN reduction followed spectrophotometrically. These assays can be performed with purified enzymes or cell lysates and are used to confirm activity of recombinant proteins [4,8]. Coupled assays with cytochrome c or cytochrome P450 can measure electron transfer to terminal acceptors [2,3].
Structural Biology and Crystallography
X-ray crystallography of ArsH and FMN-dependent NADPH-indigo reductase homologs has revealed the atomic details of FMN and NADPH binding [4,8]. These structures guide mutagenesis studies to identify catalytic residues and understand allosteric regulation. Structural comparisons across species help define conserved mechanisms [4,8].
Site-Directed Mutagenesis and Domain Deletion
Mutating the flexible linker or the FMN-binding domain of cytochrome P450 reductase can test the role of specific residues in activity. Deletion of the membrane-binding segment or the FMN domain abolishes electron transfer, confirming domain requirements. Such experiments link genotype to enzymatic function [2,3].
Cell-Based Redox and Stress Assays
Knockout or knockdown of genes encoding FMN reductases can be combined with oxidative stress challenges to measure survival [6,8]. Iron uptake assays in Leishmania or Shigella can quantify the contribution of LFR1 or ArsH to metal acquisition [6,8]. Lipid peroxidation assays can measure the impact of reductase activity on oxidative damage.
How CRISPR Can Be Used to Study GO:0052873 FMN reductase (NADPH) activity
Knockout
CRISPR knockout of genes encoding FMN reductase (NADPH) activity, such as POR or LFR1, can reveal their essential roles in electron transfer, drug metabolism, and pathogen survival [2,6]. Knockout cell lines are valuable for testing whether loss of activity alters sensitivity to oxidative stress or drugs [2,5].
Point Mutation
Point mutations in the FMN-binding domain or the flexible linker of cytochrome P450 reductase can be introduced by CRISPR to dissect structure-function relationships [2,3]. Such models help determine which residues are critical for hydride transfer or allosteric regulation [2,3].
Knock-in
Knock-in of epitope tags or fluorescent proteins into endogenous FMN reductase genes allows real-time tracking of protein localization and interactions. Tagged knock-in models can also be used to purify native complexes for biochemical assays.
Overexpression
CRISPR activation or cDNA overexpression of FMN reductases can increase enzymatic activity to study downstream effects on redox balance and metabolism [4,6]. Overexpression in bacterial or protozoan systems is useful for producing recombinant enzyme for structural and kinetic studies [4,8].
How EDITGENE Supports FMN reductase (NADPH) activity Research
Researchers studying FMN reductase (NADPH) activity-related genes often need to determine whether a candidate gene is causally involved in redox regulation, drug metabolism, or pathogen survival. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for FMN reductase (NADPH) activity research.
Frequently Asked Questions About FMN reductase (NADPH) activity
What is FMN reductase (NADPH) activity?
It is a molecular function defined by GO:0052873 that catalyzes the reaction FMNH2 + NADP+ = FMN + NADPH + 2 H+, using NADPH to reduce FMN.
What genes are involved in FMN reductase (NADPH) activity?
Genes include POR (cytochrome P450 reductase), ArsH, LFR1, and FMN-dependent NADPH-indigo reductase homologs [2,6,8].
What is the GO ID for FMN reductase (NADPH) activity?
The GO ID is GO:0052873.
What is the synonym for FMN reductase (NADPH) activity?
The synonym is NADPH dehydrogenase (FMN) activity.
How is FMN reductase (NADPH) activity measured?
It is measured by NADPH oxidation at 340 nm or by coupled cytochrome c reduction assays [2,8].
What diseases are linked to FMN reductase (NADPH) activity?
It is linked to drug metabolism disorders, leishmaniasis, and oxidative stress-related conditions [2,5,6].
What is the role of the FMN domain in cytochrome P450 reductase?
The FMN domain receives electrons from NADPH and transfers them to cytochrome P450 enzymes [2,3].
How is FMN reductase (NADPH) activity regulated?
It is regulated by allosteric modulation, linker flexibility, and NADPH availability [2,3].
Can CRISPR be used to study FMN reductase (NADPH) activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are used to study its function [2,6,8].
What model systems are used for FMN reductase (NADPH) activity research?
Common models include human cell lines, Leishmania, Shigella, yeast, and recombinant E. coli [4,6,7,8].
Conclusion
FMN reductase (NADPH) activity (GO:0052873) is a fundamental redox reaction that supplies reduced FMN for diverse cellular processes, from drug metabolism to pathogen iron acquisition. Its integration into multidomain enzymes such as cytochrome P450 reductase highlights the importance of allosteric regulation and protein-protein interactions. Continued research using CRISPR models and structural biology will further illuminate its roles in health and disease.
References
- 1. Stok JE et al.. 2015. Cytochrome P450cin (CYP176A1).. Adv Exp Med Biol 851:319-39 PMID: 26002741
- 2. Burris-Hiday SD et al.. 2023. Allosteric modulation of cytochrome P450 enzymes by the NADPH cytochrome P450 reductase FMN-containing domain.. J Biol Chem 299(9):105112 PMID: 37517692
- 3. Rwere F et al.. 2024. A flexible linker of 8-amino acids between the membrane binding segment and the FMN domain of cytochrome P450 reductase is necessary for optimal activity.. J Inorg Biochem 259:112667 PMID: 39032346
- 4. Yoneda K et al.. 2025. Structural and Functional Characteristics of FMN-Dependent NADPH-Indigo Reductase Homolog from Bacillus cohnii.. J Nutr Sci Vitaminol (Tokyo) 71(2):180-183 PMID: 40301060
- 5. Kamataki T et al.. 1978. Lipid peroxidation activity mediated by NADPH-cytochrome C reductase purified from rabbit liver microsomes.. Jpn J Pharmacol 28(6):819-27 PMID: 218031
- 6. Rocco-Machado N et al.. 2019. Leishmania amazonensis ferric iron reductase (LFR1) is a bifunctional enzyme: Unveiling a NADPH oxidase activity.. Free Radic Biol Med 143:341-353 PMID: 31446054
- 7. Johnson MS et al.. 1985. Studies on NADH (NADPH)-cytochrome c reductase (FMN-containing) from yeast. Isolation and physicochemical properties of the enzyme from top-fermenting ale yeast.. J Biol Chem 260(22):12341-50 PMID: 3930493
- 8. Vorontsov II et al.. 2007. Crystal structure of an apo form of Shigella flexneri ArsH protein with an NADPH-dependent FMN reductase activity.. Protein Sci 16(11):2483-90 PMID: 17962405
